Insider · CIK 0001398598

Birner Hubert

Reports to the SEC for 7 companies · NORTHBROOK, IL

sec.gov

Transactions

Companies

Filings

CIK

0001398598

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-06-08	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+12.7K sh	—	—	12,700
2017-06-20	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+6,666 sh	—	—	6,666
2017-01-19	ARGOS THERAPEUTICS INCStock Option (right to buy)A Award	Director	AAward	+9,500 sh	—	—	9,500
2016-12-31	ARGOS THERAPEUTICS INCA Award	Director	AAward	+3,571 sh	—	—	12,680
2016-09-30	ARGOS THERAPEUTICS INCA Award	Director	AAward	+3,521 sh	—	—	9,109
2016-06-30	ARGOS THERAPEUTICS INCA Award	Director	AAward	+2,854 sh	—	—	5,588
2016-06-29	ARGOS THERAPEUTICS INCCommon Stock Warrants (right to buy)P Purchase	Director	PPurchase	+207K sh	—	—	206,659
2016-06-29	ARGOS THERAPEUTICS INCP Purchase	Director	PPurchase	+276K sh	—	—	1,930,333
2016-06-13	ARGOS THERAPEUTICS INCStock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2016-06-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+6,666 sh	—	—	6,666
2016-03-31	ARGOS THERAPEUTICS INCA Award	Director	AAward	+2,734 sh	—	—	2,734
2016-03-14	ARGOS THERAPEUTICS INCCommon Stock Warrants (right to buy)P Purchase	Director	PPurchase	+138K sh	—	—	137,773
2016-03-14	ARGOS THERAPEUTICS INCP Purchase	Director	PPurchase	+184K sh	—	—	1,654,788
2015-06-17	ARGOS THERAPEUTICS INCStock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2015-06-02	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+6,666 sh	—	—	6,666
2014-10-27	TARAProtara Therapeutics, Inc. · Series D Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.28M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Warrants (Right to Buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−117K sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Warrants (Right to Buy)X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−39.9K sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Option (Right to Purchase)J Other	Director, 10% Owner	JOther	−1.32M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Option (Right to Purchase)J Other	Director, 10% Owner	JOther	−451K sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series A-1 Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−717K sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+223K sh	$10.00	+$2.23M	223,410
2014-10-27	TARAProtara Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+76.6K sh	$10.00	+$766K	300,000
2014-10-27	TARAProtara Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+1.11M sh	—	—	1,407,154
2014-10-27	TARAProtara Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+379K sh	—	—	1,786,616
2014-10-27	TARAProtara Therapeutics, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+117K sh	$4.60	+$536K	1,903,127
2014-10-27	TARAProtara Therapeutics, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+39.9K sh	$4.60	+$184K	1,943,059
2014-10-27	TARAProtara Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−4.47M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.53M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series A-1 Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−2.09M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−2.44M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−835K sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−2.33M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−799K sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Series D Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−3.73M sh	—	—	0
2014-02-12	ARGOS THERAPEUTICS INCC Conversion	Director	CConversion	+666K sh	—	—	768,136
2014-02-12	ARGOS THERAPEUTICS INCC Conversion	Director	CConversion	+663K sh	—	—	1,431,218
2014-02-12	ARGOS THERAPEUTICS INCP Purchase	Director	PPurchase	+39.9K sh	$8.00	+$319K	1,471,091
2014-02-12	ARGOS THERAPEUTICS INCSeries B Preferred StockC Conversion	Director	CConversion	−8,202 sh	—	—	0
2014-02-12	ARGOS THERAPEUTICS INCSeries C Preferred StockC Conversion	Director	CConversion	−94.4K sh	—	—	0
2014-02-12	ARGOS THERAPEUTICS INCSeries D Preferred StockC Conversion	Director	CConversion	−666K sh	—	—	0
2014-02-12	ARGOS THERAPEUTICS INCSeries E Preferred StockC Conversion	Director	CConversion	−663K sh	—	—	0
2014-02-12	ARGOS THERAPEUTICS INCC Conversion	Director	CConversion	+94.4K sh	—	—	102,553
2014-02-12	ARGOS THERAPEUTICS INCC Conversion	Director	CConversion	+8,202 sh	—	—	8,202
2011-08-02	Horizon Therapeutics Public Ltd CoC Conversion	Director	CConversion	+27.4K sh	$9.00	+$246K	161,648
2011-08-02	Horizon Therapeutics Public Ltd CoP Purchase	Director	PPurchase	+33.9K sh	$9.00	+$305K	195,530
2011-08-02	Horizon Therapeutics Public Ltd CoC Conversion	Director	CConversion	+409K sh	—	—	409,116
2011-08-02	Horizon Therapeutics Public Ltd CoC Conversion	Director	CConversion	+74.5K sh	—	—	483,627
2011-08-02	Horizon Therapeutics Public Ltd CoC Conversion	Director	CConversion	+98.8K sh	$9.00	+$889K	582,411
2011-08-02	Horizon Therapeutics Public Ltd CoP Purchase	Director	PPurchase	+122K sh	$9.00	+$1.1M	704,691

Recent filings

Accepted (ET)
Jun 114
Birner Hubert0001171843-18-004577
SEC(opens sec.gov)
Jun 214
PROTEON THERAPEUTICS INC0001171843-17-003742
SEC(opens sec.gov)
Jan 204
ARGOS THERAPEUTICS INC0001398598-17-000002
SEC(opens sec.gov)
Jan 44
ARGOS THERAPEUTICS INC0001398598-17-000001
SEC(opens sec.gov)
Oct 34
ARGOS THERAPEUTICS INC0001398598-16-000005
SEC(opens sec.gov)
Jul 54
ARGOS THERAPEUTICS INC0001398598-16-000004
SEC(opens sec.gov)
Jul 14
ARGOS THERAPEUTICS INC0000899243-16-024115
SEC(opens sec.gov)
Jun 154
PROTEON THERAPEUTICS INC0001171843-16-010685
SEC(opens sec.gov)
Jun 144
ARGOS THERAPEUTICS INC0001398598-16-000003
SEC(opens sec.gov)
Apr 44
ARGOS THERAPEUTICS INC0001398598-16-000002
SEC(opens sec.gov)
Mar 164
ARGOS THERAPEUTICS INC0000899243-16-016128
SEC(opens sec.gov)
Jun 194
ARGOS THERAPEUTICS INC0001398598-15-000001
SEC(opens sec.gov)
Jun 34
PROTEON THERAPEUTICS INC0001104659-15-043088
SEC(opens sec.gov)
Oct 304
PROTEON THERAPEUTICS INC0001104659-14-075072
SEC(opens sec.gov)

Companies

Address

C/O HORIZON PHARMA, INC. 1033 SKOKIE BLVD., SUITE 355

NORTHBROOK, IL, 60062